---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-109855"
form_type: "8-K"
ticker: "ZURA"
cik: "0001855644"
company_name: "Zura Bio Ltd"
filed_at: "2024-10-18T23:59:59+00:00"
generated_at: "2026-05-30T12:49:58.375972+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Zura Bio CSO Michael Howell departs effective Oct 15, 2024; no successor named

## Summary
- Chief Scientific Officer Michael Howell separated from Zura Bio on October 15, 2024.
- Separation not related to financial or operating results or any disagreements.
- No replacement for the CSO position has been announced.

## SEC filing metadata
- accession: 0001104659-24-109855
- form_type: 8-K
- ticker: ZURA
- cik: 0001855644
- company_name: Zura Bio Ltd
- filed_at: 2024-10-18T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1855644/000110465924109855/0001104659-24-109855-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1855644/000110465924109855/tm2426509d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-109855
- JSON: https://secwatch.observer/filing/0001104659-24-109855.json
- Plain text: https://secwatch.observer/filing/0001104659-24-109855.txt

## Key facts
- Executive change
  Michael Howell departed as Chief Scientific Officer at Zura Bio Ltd.
  - Action: separated
  - Role: Chief Scientific Officer
  source text: On and effective October 15, 2024, Michael Howell, the Chief Scientific Officer of Zura Bio Limited (the “ Company ”), was separated from the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1855644/000110465924109855/0001104659-24-109855-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.